Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Alzheimer's Disease using a recognised set of medical diagnostic guidelines known as the NINCDS-ADRDA criteria
- People who are older than 55 years of age
- People whose dementia severity falls within a specific range (a score of 1 to 2) on a standard assessment scale called the Clinical Dementia Rating Scale, which covers mild to moderate dementia
- People who do not have any other condition that affects memory or thinking
- People who are willing to participate in the study voluntarily
Who may not be able to join:
- People whose own consent, or the consent of a relative, is not provided
- People who are unable to take part in the full study process — for example, because they live in a different city
- People who have a history of head injury combined with alcohol or substance misuse
- People who have had a severe stroke or have other significant neurological conditions affecting the nervous system
- People who have a metal implant in the head, a pacemaker, or any other reason that a brain stimulation technique called TMS would not be safe for them
- People who are currently taking, have recently taken (within the past month), or are enrolled in a study involving an experimental drug targeting Alzheimer's disease, or a brain stimulation treatment such as TCS or TMS — other than standard approved Alzheimer's medications — that could affect the study results (confirm with trial site for full details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lutfu Hanoglu, Prof. DR. MD, Medipol University
Phone: +90 444 8 544
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Mini Mental State Examination; Neuropsychiatric Inventory; Alzheimer's Disease Assessment Scale; ADSL; Geriatric Depression Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.